NOTCH3 and depressive symptom measurement: To elucidate the mechanisms underlying NOTCH3 activation in depression-associated GC progression, we performed comparative transcriptomics between TCGA-STAD database and CUS-treated PDX cohorts, identifying that 213 overlapping DEGs were identified (Figure 3A,B).